Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2007
10/11/2007US20070238756 Combinations of dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
10/11/2007US20070238754 1-Cyclohexylmethyl-5-(2,5-dimethoxy-phenyl)-2-methyl-1H-pyrrole-3-carboxylic acid cyclohexylamide and 2-(5-Chloro-2-methoxy-phenyl)-1-(2-cyclohexyl-ethyl)-5-methyl-1H-imidazole-4-carboxylic acid cyclohexylamide; treating obesity, eating disorders; antidiabetic agents; antiinflammatory agents; drug abuse
10/11/2007US20070238753 Pharmaceutical Compositions as Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV)
10/11/2007US20070238735 Cyclooxygenase-2 selective inhibitors, compositions and methods of use
10/11/2007US20070238728 Novel dipeptidyl peptidase iv inhibitors, process for their preparation and compositions containing them
10/11/2007US20070238683 Modified and stabilized gdf propeptides and uses thereof
10/11/2007US20070238649 Agents for Regulating Adiponectin Receptor Expression
10/11/2007US20070237845 Methods and materials for reducing or eliminating risk factors associated with syndrome x
10/11/2007US20070237825 Reusable, nonbioadhesive, microporous hydrogel for hydrating and dehydrating dermatological surfaces prepared from hydroxyalkyl (meth)acrylate, a crosslinking agent, water, aliphatic alcohol (isopropanol), and a fibrous filler
10/11/2007US20070237786 Diet supplement for causing rapid weight loss, controlling appetite, managing stress, supporting relaxation, combating fatigue and supporting mental well-being.
10/11/2007CA2778823A1 Treatments using citrulline
10/11/2007CA2649045A1 Pharmaceutical composition
10/11/2007CA2648598A1 Lactate and calcium containing pharmaceutical composition and uses thereof
10/11/2007CA2648351A1 Regulating fat and carbohydrate oxidation in muscle tissue
10/11/2007CA2648028A1 Bicyclooctane derivatives, preparation process and pharmaceutical use thereof
10/11/2007CA2647472A1 Organic compounds
10/11/2007CA2645245A1 Compositions and methods for treating atherosclerosis
10/11/2007CA2644963A1 Organic compounds
10/11/2007CA2644636A1 Ceramide kinase modulation
10/11/2007CA2629321A1 Glucagon receptor antagonists, preparation and therapeutic uses
10/10/2007EP1842850A1 Rosiglitazone hydrochloride hemihydrate
10/10/2007EP1842846A1 Phenylpiperidine derivatives as melanocortin-4 receptor modulators
10/10/2007EP1842551A1 E-selectin for treating or preventing stroke
10/10/2007EP1842540A1 Sesamin/episesamin compositions
10/10/2007EP1842431A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
10/10/2007EP1841796A2 Bispecific domain antibodies targeting serum albumin and glp-1 or pyy
10/10/2007EP1841781A1 Use of il-22 for the treatment of conditions of metabolic disorders
10/10/2007EP1841770A2 Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
10/10/2007EP1841749A1 Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases
10/10/2007EP1841734A2 5-aminoindole derivatives
10/10/2007EP1841731A1 Substituted aminomethylene sulphonamides, production and use thereof as medicaments
10/10/2007EP1841436A1 Compounds and methods for regulating triglyceride levels
10/10/2007EP1841419A1 Cathepsin k inhibitors and obesity
10/10/2007EP1841415A2 Use of sirtuin-activating compounds for treating flushing and drug induced weight gain
10/10/2007EP1581515B1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
10/10/2007EP1558252B1 Substituted furo [2,3-b]pyridine derivatives
10/10/2007EP1525200B1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/10/2007EP1511509B1 Compositions and methods for treating diabetes
10/10/2007EP1490058B1 Peroxisome proliferator activated receptor modulators
10/10/2007EP1442019B1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
10/10/2007EP1399153B1 Pharmaceutical composition comprising orlistat and a fatty acid or salt thereof
10/10/2007EP1354884B1 Cyclopenta[d]pyrazolo[1,5-a]pyrimidine compound as crf receptor antagonist
10/10/2007EP1347990B1 Peptides having inhibiting activity to nitric oxyde production
10/10/2007EP1332132B1 Enamine derivatives as cell adhesion molecules
10/10/2007EP1319007B9 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/10/2007EP1249450B1 Benzimidazole derivatives as human chymase inhibitors
10/10/2007EP1232150B1 Urea derivatives as anti-inflammatory agents
10/10/2007EP1142879B1 Imidazole compounds and medicinal use thereof
10/10/2007EP0967892B2 Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive
10/10/2007CN101052657A Method for production of indigestible dextrin comprising isoglucose
10/10/2007CN101052632A Dibenzosuberone derivatives
10/10/2007CN101052623A Phenanthridine carbonyl phenols as cytokine modulators
10/10/2007CN101052621A 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
10/10/2007CN101052405A Combination of polychitosamine and HMG-COA reductase inhibitor for hyperlipidemia
10/10/2007CN101052391A Peroxisome proliferator-activated receptor (PPAR) activator, and drugs, supplements, functional foods and food additives using the same
10/10/2007CN101052381A Bilayer tablet comprising telmisartan and amlodipine
10/10/2007CN101052316A Nutrition containing fat blend
10/10/2007CN101050215A Spiroazacyclic compounds as monoamine receptor modulators
10/10/2007CN101050199A (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
10/10/2007CN101050011A Membrane filtered drinkable mineral raw water containing selenium and germanium
10/10/2007CN101049500A Composition of amino acid
10/10/2007CN101049462A í«Naoxinaní» tablet in use for cardiovascular disease, cerebrovascular disease and preparation method
10/10/2007CN101049451A Application of compound preparation in medication for treating generalized bone fracture, weight reduction, and fighting against senium
10/10/2007CN101049440A Preparation of Chinese traditional medicine in use for diabetes, and preparation method
10/10/2007CN101049382A External spraying agent for treating circulatory disturbance of blood vessels of heart and brain
10/10/2007CN101049380A Enteric solubility soft capsule containing camellia oil, and preparation method
10/10/2007CN101049377A Health protection tea for reducing blood pressure, and blood fat, and preparation method
10/10/2007CN101049356A Pharmaceutical composition of containing puerarin and leaves of hawthorn
10/10/2007CN101049348A Chinese traditional medicine for treating hyperlipemia, and preparation method
10/10/2007CN101049328A Technique for producing extractive of olive growing leaves
10/10/2007CN101049320A Buccal tablets of extractive of propolis alcohol
10/10/2007CN101049319A Composition for improving remembrance
10/10/2007CN101049299A PravastatinNa pills, and preparation method
10/10/2007CN101049297A High DNA type fatty ethyl ester in high purity, manufacturing method and preparation
10/10/2007CN101049283A Slim and shaping frost, and preparation method
10/10/2007CN101049170A Beautification beverage of lilyturf root, scullcap
10/10/2007CN101049154A Slim diet therapy package of tuckahoe
10/10/2007CN101049141A Soup dishes of edible cactus
10/10/2007CN101049140A Cold dishes of edible cactus
10/10/2007CN101049139A Steaming and boiling dishes of edible cactus
10/10/2007CN101049138A A fried dish group of edible cactus
10/10/2007CN101049123A Method for preparing tea of natural pine needle meal
10/10/2007CN100341885C Process for selective production of aryl 5-thio-beta-d-aldohexopyranosides
10/10/2007CN100341870C Glycosidase inhibitors and preparation thereof
10/10/2007CN100341862C Thiazolidine derivative and medicinal use thereof
10/10/2007CN100341824C Animal and plant high effect ecological nutritive liquid and its preparation method
10/10/2007CN100341578C Anhydrous topical skin preparations
10/10/2007CN100341567C Compositions for nasal administration of insulin
10/10/2007CN100341547C Medicinal composition for regulating blood fat, prepn. method and use thereof
10/10/2007CN100341535C Natural liver protection and fat clearing product
10/10/2007CN100341525C Compositions and methods for treatment of diabetes
10/10/2007CN100341523C Volatile liquid composition for inhibiting hyperglycemia, and its volatiling device and its use
10/10/2007CN100341509C Medicinal composition for mitigating blood lipid or lowering blood homocysteine
10/10/2007CN100341501C Health care food containing dihydromyricetin and myricetin composition
10/10/2007CN100341496C Preventive or therapeutic agent for kidney disease
10/10/2007CN100341495C Solid dispersion and preoral combination of glibenclamide and preparation method
10/10/2007CN100341493C Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
10/10/2007CN100341428C Nutritional composition preventing bacterial overgrowth
10/10/2007CN100341416C Health food containing ampeloptin
10/09/2007US7279596 Stable crystals of substituted phenylpropionic acid derivative and process for producing the same
1 ... 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 ... 1298